1750419438

1750419438 was paid $915K by Medicaid between Jan 2018 and Nov 2024, across 76 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 23% of everything it billed.

33Billing provider info1750419438

33aNPI1750419438

33bProvider type—

28Total paid$915K

24GClaims248,600

24DCodes billed76

24AFirst – last monthJan 2018 – Nov 2024

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	57,829	$175K
2019	28,812	$185K
2020	25,224	$102K
2021	35,912	$121K
2022	40,472	$118K
2023	54,808	$158K
2024incomplete	5,543	$54K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	23%	34,512	32,253	$213K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	14%	3,772	3,678	$130K
92552		13%	16,473	16,416	$120K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	6.6%	8,473	8,321	$60K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	5.2%	6,030	5,816	$47K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	4.4%	9,527	9,295	$40K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	3.8%	8,584	8,455	$35K
99381		2.9%	330	283	$26K
90686		2.4%	5,227	5,185	$22K
90648		2.3%	3,983	3,955	$21K
90670		2.3%	4,077	4,056	$21K
G9920	Screening performed and negative	2.3%	12,529	12,502	$21K

64 more codes

90723		2.0%	2,981	$18K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	1.9%	4,905	$17K
90680		1.4%	2,036	$13K
90716		1.3%	2,673	$12K
90707		1.2%	2,621	$11K
90633		1.0%	2,344	$9K
86580		<1%	2,467	$9K
90651		<1%	2,063	$9K
90734		<1%	1,582	$6K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	5,676	$6K
90696		<1%	1,221	$5K
0001A		<1%	92	$4K
99215	Doctor's office visit, returning patient (complex)	<1%	281	$3K
90700		<1%	762	$3K
90715		<1%	791	$3K
90620		<1%	595	$3K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	689	$3K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	1,426	$2K
85018		<1%	16,724	$2K
99460		<1%	40	$2K
99491	Ccm add 20min	<1%	372	$2K
81003		<1%	17,065	$2K
92551		<1%	3,029	$2K
0002A		<1%	44	$2K
99383		<1%	110	$1K
90472	Immunization administration, each additional vaccine (list separately)	<1%	2,689	$1K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	452	$963.96
94760		<1%	26,251	$934.77
G8510	Screening for depression is documented as negative, a follow-up plan is not required	<1%	4,149	$851.20
90685		<1%	163	$801.63
99173		<1%	17,608	$712.50
99382		<1%	29	$379.57
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	82	$364.35
G2010	Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment	<1%	1,327	$357.85
90656		<1%	13	$325.00
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	31	$310.52
99490	Ccm add 20min	<1%	234	$267.96
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	621	$198.28
81001		<1%	92	$193.40
G9919	Screening performed and positive and provision of recommendations	<1%	41	$116.00
99417	Prolong home eval add 15m	<1%	27	$112.40
83655		<1%	13	$105.14
96150		<1%	795	$92.81
H0049	Alcohol and/or drug screening	<1%	534	$25.00
G8431	Screening for depression is documented as being positive and a follow-up plan is documented	<1%	67	$9.90
96160		<1%	3,519	$7.11
92587		0%	809	$0.00
90677		0%	15	$0.00
1036F		0%	1,490	$0.00
3008F		0%	60	$0.00
99384		0%	42	$0.00
99441		0%	50	$0.00
J7609	Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg	0%	80	$0.00
92560		0%	67	$0.00
81000		0%	204	$0.00
99439		0%	13	$0.00
17000		0%	28	$0.00
3725F		0%	701	$0.00
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	0%	55	$0.00
99401		0%	56	$0.00
82948		0%	30	$0.00
90460	Immunization administration through 18 years of age via any route, first or only component	0%	32	$0.00
90710		0%	13	$0.00
99201		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.